Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Nucleinate and FOLFOX in Metastatic Colorectal Cancer
NCT06509880Phase 3Completed
- Sponsor
- MIPO Clinic
- Start
- Jul 2022
- Primary completion
- Jul 2023
- Modality
- DNA Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of sodium nucleinate in colorectal cancer (CRC), sponsored by MIPO Clinic. Started Jul 2022; status: completed.
02
Drugs
sodium nucleinate
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06509880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06509880.